Open AccessComparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
Author(s) -
David J. Wilber,
Carlo Pappone,
Petr Neužil,
Angelo de Paola,
Francis E. Marchlinski,
Andrea Natale,
Laurent Macle,
Emile G. Daoud,
Hugh Calkins,
Burr Hall,
Vivek Y. Reddy,
Giuseppe Augello,
Matthew R. Reynolds,
Chandan Vinekar,
Christine Y. Liu,
Scott Berry,
Donald A. Berry,
for the ThermoCool AF Trial Investigators
Publication year - 2010
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2009.2029
Subject(s) - medicine , atrial fibrillation , catheter ablation , ablation , adverse effect , randomization , catheter , hazard ratio , randomized controlled trial , surgery , confidence interval , prospective cohort study , anesthesia , cardiology
Antiarrhythmic drugs are commonly used for prevention of recurrent atrial fibrillation (AF) despite inconsistent efficacy and frequent adverse effects. Catheter ablation has been proposed as an alternative treatment for paroxysmal AF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom